Status:
COMPLETED
Development of Assessment Method for Driving Ability Using Driving Simulator in Healthy Volunteers #2
Lead Sponsor:
Taisho Pharmaceutical Co., Ltd.
Collaborating Sponsors:
Nagoya University
Conditions:
Healthy Participants
Eligibility:
MALE
21-64 years
Phase:
NA
Brief Summary
The purpose of this study is to verify the intra-individual difference of the SDLP values in driving simulator.
Eligibility Criteria
Inclusion
- Body mass index (BMI) ≥18.5 and \<25.0 kg/m2 at screening inspection
- No visual impairment (enable to correct the vision with eyeglasses or contact lens)
- Receive a prior explanation on the study, able to accept its content, and capable to provide voluntary written consent for participation in this study
Exclusion
- History of drug and food allergy
- Routinely drink alcohol before bedtime
- Inappropriate for enrollment in this study was judged by principal investigator or subinvestigator
Key Trial Info
Start Date :
January 22 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03413592
Start Date
January 22 2018
End Date
April 30 2018
Last Update
February 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taisho Pharmaceutical Co., Ltd selected site
Fukuoka, Japan